CMHSD — Comprehensive Healthcare Systems Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $1.73m
- $4.22m
- $3.77m
Annual income statement for Comprehensive Healthcare Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 4.5 | 4.3 | 3.84 | 3.77 |
Cost of Revenue | ||||
Gross Profit | 1.37 | 1.4 | 1.15 | 2.06 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 8.4 | 9.1 | 7.17 | 4.18 |
Operating Profit | -3.91 | -4.79 | -3.33 | -0.412 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -4.93 | -5.11 | -3.58 | -0.608 |
Net Income After Taxes | -4.93 | -5.11 | -3.58 | -0.608 |
Net Income Before Extraordinary Items | ||||
Net Income | -4.93 | -5.11 | -3.58 | -0.608 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -4.93 | -5.11 | -3.58 | -0.608 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -2.32 | -1.49 | -0.578 | -0.19 |